Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices-Reference-Cited by-同舟云学术

Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices

Published:1992-04 Issue:4 Volume:166 Page:1208-1213
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Sivin Irving,Stern Janet,Diaz Soledad,Pavéz Margarita,Alvarez Francisco,Brache Vivian,Mishell Daniel R.,Lacarra Maria,McCarthy Terence,Holma Pentti,Darney Philip,Klaisle Cynthia,Olsson Sven-Eric,Odlind Viveca

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference25 articles.

1. A long-term follow-up study of women using different methods of contraception, an interim report;Vessey;J Biosoc Sci,1976

2. Depo-medroxyprogester-one acetate as a contraceptive agent;McDaniel;Contraception,1973

3. Return of fertility after discontinuation of depo-medroxyprogesterone acetate and intrauterine devices in Northern Thailand;Pardthaisong;Lancet,1980

4. Task Force on Hormonal Contraception: return of fertility following discontinuation of an injectable contraceptive—norethisterone oenanthate (NET EN) 200 mg dose;Contraception,1986

5. Primary tubal infertility in relation to the use of an intrauterine device;Daling;N Engl J Med,1985

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential biomarkers to predict return to fertility after discontinuation of female contraceptives—looking to the future;Frontiers in Reproductive Health;2023-08-22

2. Fertility return after hormonal contraceptive discontinuation and associated factors among women attended Family Guidance Association of Ethiopia Dessie model clinic, Northeast Ethiopia: A cross-sectional study;PLOS ONE;2023-07-11

3. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial;American Journal of Obstetrics and Gynecology;2022-12

4. Uterine synechiae after intrauterine device use: a case series;Journal of Assisted Reproduction and Genetics;2021-04-08

5. Controversies in Contraception;The Handbook of Contraception;2020